CureVac's market cap is currently $1.21B. The company's EPS TTM is $-0.17584575; its P/E ratio is 5.91; CureVac is scheduled to report earnings on August 15, 2025, and the estimated EPS forecast is $0.11. See an overview of income statement, balance sheet, and cash flow financials.
